Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MR1Z
|
|||
| Former ID |
DNC010420
|
|||
| Drug Name |
Benzaldehyde O-4-butoxyphenylcarbamoyl oxime
|
|||
| Synonyms |
CHEMBL598243; benzaldehyde O-4-butoxyphenylcarbamoyl oxime
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H20N2O3
|
|||
| Canonical SMILES |
CCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2
|
|||
| InChI |
1S/C18H20N2O3/c1-2-3-13-22-17-11-9-16(10-12-17)20-18(21)23-19-14-15-7-5-4-6-8-15/h4-12,14H,2-3,13H2,1H3,(H,20,21)/b19-14+
|
|||
| InChIKey |
BRPRTDQSLVFYMR-XMHGGMMESA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.